• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壬苯醇醚-9作为阴道杀菌剂的安全性研究:不良反应证据

Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.

作者信息

Stafford M K, Ward H, Flanagan A, Rosenstein I J, Taylor-Robinson D, Smith J R, Weber J, Kitchen V S

机构信息

Department of Genitourinary Medicine and Communicable Diseases, Chelsea and Westminster Hospital, England.

出版信息

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):327-31. doi: 10.1097/00042560-199804010-00006.

DOI:10.1097/00042560-199804010-00006
PMID:9525433
Abstract

Nonoxynol-9 (N-9) is virucidal in vitro, and is therefore a candidate microbicide for preventing sexual transmission of HIV. However, the activity of N-9 is nonspecific, suggesting that virucidal levels may produce adverse effects including epithelial disruption, inflammation of the genital mucosa, or both. A randomized placebo controlled trial of daily use of 100 mg of N-9 took place for 1 week in 40 female volunteers. Outcome measures included symptoms, colposcopic and histologic changes in the genital tract, and impact on vaginal flora. Genital irritation was reported by 10 of the N-9 and 5 of the placebo group. Colposcopy showed erythema in 9 of the N-9 group and 2 of the placebo group. Histologic inflammation was found in 7 of the N-9 group and 2 of the placebo group. Inflammatory changes were characterized by patchy infiltration of the lamina propria predominantly with CD8+ lymphocytes and macrophages, in the absence of epithelial disruption. A transient reduction in numbers of lactobacilli was observed in 9 of the 15 women using N-9, and 6 of 18 women using placebo. N-9 used for 7 days in a standard spermicidal dose was associated with increased irritation, colposcopic and histologic evidence of inflammation and was more frequently associated with reduction in numbers of lactobacilli during gel use. The clinical significance of the recruitment of cells susceptible to HIV infection to the genital mucosa is unknown but raises concerns about the suitability of N-9 as a microbicide when given in this dose.

摘要

壬苯醇醚 -9(N -9)在体外具有杀病毒作用,因此是预防艾滋病毒性传播的候选杀微生物剂。然而,N -9的活性是非特异性的,这表明其杀病毒水平可能会产生不良反应,包括上皮破坏、生殖黏膜炎症或两者皆有。一项针对40名女性志愿者的随机安慰剂对照试验进行了1周,她们每日使用100毫克N -9。结果指标包括症状、生殖道的阴道镜和组织学变化以及对阴道菌群的影响。N -9组有10名志愿者报告有生殖器刺激症状,安慰剂组有5名。阴道镜检查显示,N -9组有9名出现红斑,安慰剂组有2名。组织学炎症在N -9组发现7例,安慰剂组发现2例。炎症变化的特征是固有层有片状浸润,主要为CD8 +淋巴细胞和巨噬细胞浸润,且无上皮破坏。在使用N -9的15名女性中有9名以及使用安慰剂的18名女性中有6名观察到乳酸杆菌数量短暂减少。以标准杀精剂量使用7天的N -9与刺激增加、炎症的阴道镜和组织学证据相关,并且在使用凝胶期间更频繁地与乳酸杆菌数量减少相关。向生殖黏膜募集易感染艾滋病毒的细胞的临床意义尚不清楚,但这引发了对以该剂量使用N -9作为杀微生物剂适用性的担忧。

相似文献

1
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.壬苯醇醚-9作为阴道杀菌剂的安全性研究:不良反应证据
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):327-31. doi: 10.1097/00042560-199804010-00006.
2
Nonoxynol-9 in lubricated condoms. Results of a study in female prostitutes.
Sex Transm Dis. 1996 Sep-Oct;23(5):413-4. doi: 10.1097/00007435-199609000-00012.
3
A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.壬苯醇醚9膜预防男性向女性传播性传播疾病的对照试验。
N Engl J Med. 1998 Aug 20;339(8):504-10. doi: 10.1056/NEJM199808203390803.
4
A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.含壬苯醇醚-9的三种避孕阴道膜的I期对照研究。性交后检测与阴道镜检查。
Contraception. 1997 Aug;56(2):97-102. doi: 10.1016/s0010-7824(97)00099-1.
5
Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. A randomized clinical trial.壬苯醇醚-9阴道凝胶在肯尼亚妓女中的安全性。一项随机临床试验。
Sex Transm Dis. 1997 May;24(5):279-83. doi: 10.1097/00007435-199705000-00008.
6
Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.阴道对一种具有酸缓冲作用的生物粘附凝胶——酸福尔姆耐受性的研究。
Contraception. 1999 Dec;60(6):361-6. doi: 10.1016/s0010-7824(99)00102-x.
7
Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection.壬苯醇醚-9凝胶在低感染HIV风险女性中的安全性评估。
AIDS. 1998 Mar 5;12(4):433-7. doi: 10.1097/00002030-199804000-00013.
8
Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa.壬苯醇醚-9 100毫克凝胶:来自撒哈拉以南非洲的多中心安全性研究。
AIDS. 2004 Nov 5;18(16):2191-5. doi: 10.1097/00002030-200411050-00012.
9
Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina).多次应用苯扎氯铵和壬苯醇醚9对豚尾猕猴(食蟹猴)阴道上皮的影响。
Am J Obstet Gynecol. 1999 May;180(5):1080-7. doi: 10.1016/s0002-9378(99)70598-3.
10
A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II.一项关于三种浓度的C31G与超强Gynol II的随机I期阴道安全性研究。
Contraception. 2004 Sep;70(3):233-40. doi: 10.1016/j.contraception.2004.04.010.

引用本文的文献

1
Vaginal irritation testing-prospects of human organotypic vaginal tissue culture models.阴道刺激测试——人源组织型阴道组织培养模型的前景。
In Vitro Cell Dev Biol Anim. 2024 Jun;60(6):569-582. doi: 10.1007/s11626-024-00907-1. Epub 2024 Jul 12.
2
S-Nitroso-N-acetylpenicillamine impregnated latex: A new class of barrier contraception for the prevention of intercourse-associated UTIs.S-亚硝基-N-乙酰青霉胺浸渍胶乳:一类用于预防性行为相关 UTIs 的新型屏障避孕方法。
J Biomed Mater Res B Appl Biomater. 2024 Feb;112(2):e35371. doi: 10.1002/jbm.b.35371.
3
Non-Hormonal Contraception.
非激素避孕法
J Clin Med. 2023 Jul 20;12(14):4791. doi: 10.3390/jcm12144791.
4
ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.ZB-06,一种含有工程化的人用避孕抗体(HC4-N)的阴道膜,在一项 1 期事后避孕测试和安全性研究中表现出安全性和有效性。
Am J Obstet Gynecol. 2023 Jun;228(6):716.e1-716.e12. doi: 10.1016/j.ajog.2023.02.024. Epub 2023 Mar 2.
5
Hexavalent sperm-binding IgG antibody released from vaginal film for development of potent on-demand nonhormonal female contraception.从阴道薄膜释放的六价精子结合IgG抗体用于开发高效按需非激素女性避孕药。
Proc Natl Acad Sci U S A. 2021 Nov 30;118(48). doi: 10.1073/pnas.2107832118.
6
Evaluation of the novel vaginal contraceptive agent PPCM in preclinical studies using sperm hyaluronan binding and acrosome status assays.采用精子透明质酸结合和顶体状态检测方法评估新型阴道避孕剂 PPCM 在临床前研究中的效果。
Andrology. 2022 Feb;10(2):367-376. doi: 10.1111/andr.13110. Epub 2021 Oct 4.
7
Pharmaceutical Approaches to HIV Treatment and Prevention.艾滋病病毒治疗与预防的药物方法
Adv Ther (Weinh). 2018 Oct;1(6). doi: 10.1002/adtp.201800054. Epub 2018 Jul 29.
8
Serine protease inhibitor disrupts sperm motility leading to reduced fertility in female mice†.丝氨酸蛋白酶抑制剂破坏精子运动能力,导致雌性小鼠生育力降低†。
Biol Reprod. 2020 Aug 4;103(2):400-410. doi: 10.1093/biolre/ioaa049.
9
Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237.开发一种阴道环用于局部递送 Aurora 激酶 A 抑制剂 MLN8237。
PLoS One. 2019 Nov 27;14(11):e0225774. doi: 10.1371/journal.pone.0225774. eCollection 2019.
10
Herbal Gel Formulation Developed for Anti-Human Immunodeficiency Virus (HIV)-1 Activity Also Inhibits In Vitro HSV-2 Infection.一种用于抗人类免疫缺陷病毒 (HIV)-1 活性的草药凝胶制剂也可抑制体外单纯疱疹病毒 2 型感染。
Viruses. 2018 Oct 24;10(11):580. doi: 10.3390/v10110580.